pre-IPO PHARMA
COMPANIES
VC
JOBS
NEWS
CONTACT
Close ×
COMPANIES
VC
JOBS
NEWS
CONTACT
COMPANY OVERVIEW
Neurogastrx is a private biopharmaceutical company focused on discovering and developing transformative therapies for gastrointestinal disorders affecting the enteric nervous system.
LOCATION
Woburn, MA, USA
THERAPEUTIC AREAS
Gastrointestinal Disease
WEBSITE
https://neurogastrx.com
CAREER WEBSITE
None
SOCIAL MEDIA
INVESTORS
PRESS RELEASES
Aug 26, 2021
Neurogastrx Secures $60 Million in Series B Financing and Expands Management Team to Advance Its Pipeline of Transformative Investigational Therapies for Gastrointestinal Disorders
Jun 8, 2021
Neurogastrx Announces Agreement with Daewoong Pharmaceutical to Develop Fexuprazan for Treatment of Acid-Related GI Disorders in the U.S.
Jan 4, 2018
Neurogastrx, Inc. Raises $45M Series A To Bring Lead GI Candidate Through Proof Of Concept
Nov 3, 2015
Neurogastrx Appoints Baxter Phillips III as President and Chief Executive Officer
For More Press Releases